ERVW-1 and HIV infectious disease: [13;27;55;56] Thus, a hypothesis is that vaccines that induce higher levels of V1V2 antibodies and lower levels of Env-specific IgA antibodies than that induced by the RV144 regimen may be more efficacious in preventing HIV infection.